The 22nd Awaji International Forum on Infection and Immunity

○Nobuhiko Kayagaki¹ (1. Genentech, Inc. (United States of America))

○Andrea Ablasser¹ (1. Ecole Polytechnique Fédérale de Lausanne (Switzerland))

○Tomohiko Taguchi¹ (1. Tohoku University (Japan))

○Hiroyuki Oshiumi¹ (1. Department of Immunology, Faculty of Life Sciences, Kumamoto University (Japan))

○Keiko Yasuda¹, Junichi Aoki¹, Kotaro Tanaka¹, Shintaro Shichinohe², Chikako Ono³, Alexis Vandenbon⁴, Daiya Ohara⁵, Yukiko Muramoto⁶, Songling Li⁷, Daisuke Motooka⁸, Keiji Hirota⁵, Takeshi Noda⁶, Daron M. Standley⁷, Yuzuru Ikehara⁹, Tokiko Watanabe², Yoshiharu Matsuura³, Osamu Takeuchi¹ (1. Department of Medical Chemistry Graduate School of Medicine, Kyoto University (Japan), 2. Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University (Japan), 3. Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University (Japan), 4. Laboratory of Tissue Homeostasis, Institute for Life and Medical Sciences, Kyoto University (Japan), 5. Laboratory of Integrative Biological Science, Institute for Life and Medical Sciences, Kyoto University (Japan), 6. Laboratory of Ultrastructural Virology, Institute for Life and Medical Sciences, Kyoto University (Japan), 7. Department of Genome Informatics, Research Institute for Microbial Diseases, Osaka University (Japan), 8. Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University (Japan), 9. Department of Pathology, Graduate School of Medicine, Chiba University (Japan))

○Fanchong Jian^1,2, Jing Wang^1,2, Ayijiang Yisimayi^1,2, Weiliang Song^1,2, Yanli Xu³, Yunlong Cao^1,2 (1. Peking University (China), 2. Changping Laboratory (China), 3. Beijing Ditan Hospital, Capital Medical University (China))